ABSTRACT The whole-cell patch-clamp technique was used to study voltagedependent calcium currents in primary cultures of myotubes and in freshly dissociated skeletal muscle from normal and dysgenic mice. In addition to the transient, dihydropyridine (DHP)-insensitive calcium current previously described, a maintained DHP-sensitive calcium current was found in dysgenic skeletal muscle. This current, here termed Ic~,t,, is largest in acutely dissociated fetal or neonatal dysgenic muscle and also in dysgenic myotubes grown on a substrate of killed fibroblasts. In dysgenic myotubes grown on untreated plastic culture dishes, Ic~ is usually so small that it cannot be detected. In addition, Ic~ay, is apparently absent from normal skeletal muscle. From a holding potential of -80 mV, Ic~.,a becomes apparent for test pulses to ~-20 mV and peaks at ~ + 20 mV. The current activates rapidly (rise time ~5 ms at 20~ and with 10 mM Ca as charge cattier inactivates little or not at all during a 200-ms test pulse. Thus, Ic~.,~ activates much faster than the slowly activating calcium current of normal skeletal muscle and does not display Ca-dependent inactivation like the cardiac L-type calcium current.
INTRODUCTION
Vertebrate cell membranes contain a variety of voltage-gated calcium channels that are categorized according to voltage dependence, kinetics, and pharmacology (Bean, 1989) . To date, skeletal muscle has been shown to express three distinct types of calcium currents. These are (a) a fast-activating, transient current that is insensitive to 1,4-dihydropyridine (DHP) derivatives (Beam et al., 1986; Cognard et al., 1986a; Beam and Knudson, 1988; Gonoi and Hasegawa, 1988) ; (b) a fast-activating, maintained current that is also DHP-insensitive (Cota and Stefani, 1986; Arreola et al., 1987; Garcia et al., 1988) ; and (c) a slowly-activating current that is DHP-sensitive (Donaldson and Beam, 1983; Beam et al., 1986; Cognard et al., 1986a and b; Beam and Knudson, 1988; Gonoi and Hasegawa, 1988) . In this paper, we have adopted the following nomenclature for these different currents. The fastactivating, transient current is termed Ic~.a; this current is found in developing skeletal muscle, and resembles the T-type (Nowycky et al., 1985) calcium current reported for many different cell types (Bean, 1989) . The fast-activating, maintained current is termed Ic~-fm; this current has been described for frog and mammalian skeletal muscle, and does not fit easily into the T, L or N categories of Nowycky et al. (1985) . The slowly-activating current is termed Ica-~; this current is a distinctive form of L-type calcium current characteristic of skeletal muscle.
Ic~.~ is the dominant calcium current in normal skeletal muscle. However, in skeletal muscle from mice with muscular dysgenesis, Ic~ is absent (Beam et al., 1986; Rieger et at., 1987) and excitation-contraction (E-C) coupling is nonfunctional (Powell and Fambrough, 1973; Klaus et al., 1983) . Genetic analysis indicates that the muscular dysgenesis mutation alters the structural gene for the alpha1 subunit of the skeletal muscle DHP receptor; injecting cDNA for this subunit into developing dysgenic myotubes restores both Ic~.~ and E-C coupling (Tanabe et al., 1988) . These results indicate that the alpha1 subunit of the DHP receptor is a necessary component of both the slow calcium channel and the E-C coupling mechanism.
Grown under standard tissue culture conditions, myotubes from dysgenic mice express only a single prominent calcium current, Ic~.ft (Beam et al., 1986; Rieger et al., 1987) . However, in dysgenic skeletal muscle that has developed in vivo or under special culture conditions, we have observed an additional calcium current. This current, which we term Ic~y,, is distinct, both kinetically and pharmacologically, from Ic~ and also from the other calcium currents found in skeletal muscle (Ica-ft, Ic~.fm). Ic~s does not appear to be present in normal skeletal muscle.
In this paper we describe the kinetics, voltage dependence, and pharmacology of Ic~y~ in dysgenic skeletal muscle. In addition, we compare the properties of Ica~y~ with those of other known calcium currents, especially those found in normal skeletal muscle. A preliminary account of some of the results presented here has appeared previously (Adams and Beam, 1989) .
METHODS

Voltage Clamp
Calcium currents were recorded using the whole-cell variant of the patch-clamp technique (Hamill et al., 1981) . Pipettes were fabricated from borosilicate glass and filled with an internal solution containing (millimolar) 140 Cs-aspartate, 5 MgCI~, 10 Cs~EGTA, 10 Hepes, pH 7.4 with CsOH. The resistance of the pipettes varied from 1.3 to 2.5 M-ohm. For each cell, the linear capacitative and leakage currents were measured for a depolarizing or hyperpolarizing control pulse of 10-20 mV from a holding potential of -80 inV. The area beneath the capacitative transient and the time constant of the transient's decay were used to calculate the cell's linear capacitance and the series resistance associated with the pipette (Matteson and Armstrong, 1984) . Electronic compensation was used to reduce the effective series resistance, generally to a value <1.5 M-ohm. The control current described above was scaled appropriately and used to correct test currents for linear components of capacitative and leakage currents. Test pulses were separated by an interval of at least 5 s. To allow comparison of test currents recorded from different cells, the current recorded from each cell was normalized by that cell's linear capacitance (current expressed as picoamperes per picofarad). In many of the illustrated traces, the first several data points after a change in potential have been blanked. Data were filtered at 500 Hz and sampled at 1,000 Hz. Experiments were conducted at room temperature (20-22~
Average numerical values are presented in the text and figures as mean _+ SEM.
External Solutions
Calcium channel currents were recorded while the cells were bathed in an external solution containing (millimolar) 145 TEA-C1, 10 CaC12 [or 10 BaCI~], 10 Hepes, pH 7.4 with CsOH. In addition, all external solutions contained 2-10 I~M Trx, as required, to block voltagegated sodium channels.
Cell Culture
Primary cultures of myoblasts were prepared from skeletal muscles of late-term fetal or newborn mice. The muscles were minced and then incubated at 37~ for 40-60 rain in Ca, Mgfree Ringer (155 mM NaCI, 5 mM KC1, 10 mM Hepes, pH 7.4 with NaOH) containing 0.25% (wt/vol) crude trypsin (1:250, Difco Laboratories Inc., Detroit, MI). After filtration and centrifugation to remove large debris, the cell suspension was plated at a density of 10 ~ cells/dish onto 35-ram Primaria dishes (Becton Dickinson Labware, Lincoln Park, NJ) containing an attached layer of killed fibroblasts (see below). The plating medium contained (vol/vol) 80% Dulbecco's modified Eagle's medium with 4.5 g/liter glucose (DMEM) and 20% fetal bovine serum. After 3-5 d, the plating medium was replaced with maintenance medium: 90% DMEM and 10% horse serum. All culture media contained penicillin (100 U/ml) and streptomycin (100 ~g/ml). Cultures were maintained at 37~ in a 95% air/5% COs, water-saturated atmosphere.
The substrate of killed fibroblasts was created by first growing fibroblasts to confluence on untreated culture dishes. The culture medium was then removed and the fibroblasts were exposed to deionized water for 1 rain, followed by complete dessication under ultraviolet light for 15 rain. The resultant dishes, containing a layer of lysed and dessicated fibroblasts, were then stored at 4~ until use. Fibroblasts from three different sources (NIH 3T3 cell line; skin fibroblasts from dysgenic mice and their nondysgenic littermates) were used for this purpose.
Acute Isolation of Muscle Cells
Single skeletal muscle fibers were dissociated from the plantar muscles (i.e., all the muscles on the sole of the hind foot) of fetal (day 15-20) or neonatal (1-2-d-old) mice following the procedure of Beam and Knudson (1988) .
Application of Drugs
Concentrated (1 or 10 raM) stock solutions of the DHP compounds (+)-PN 200-110 (kindly provided by Dr. A. Lindenmann and Dr. E. Rossi of Sandoz Ltd., Basel, Switzerland) and racemic Bay K 8644 (kindly supplied by Dr. A. Scriabine, Miles Laboratories, Inc., New Haven, CT) were prepared by dissolving the drugs in 100% ethanol. The stock solutions were stored in the dark at -20~ Test concentrations were prepared just before use by dilution with the external saline used for current measurement (final ethanol concentration, <0.01%). The microscope light was turned off and the room was darkened during application of these test solutions.
The effects of pharmacological agents or ionic substitution were examined by bulk exchange of the external medium with 10-20 times the bath volume of new medium. Because we found that simply replacing the bathing solution with a fresh, but identical solution tended to potentiate calcium currents, the following procedure was adopted. After stable calcium currents had been recorded from a given myotube or muscle fiber, the bath solution was replaced with identical external saline and currents were recorded both immediately and 5 rain after this first "control" solution exchange. Next, the test solution (containing Cd, Ba, or drugs) was perfused through the chamber, and calcium currents were again measured immediately and after 5 min. Finally, the test solution was washed out of the chamber and calcium currents were once more recorded immediately and 5 min afterwards. Fig. 1 illustrates the presence of two distinct calcium currents in a freshly dissociated muscle fiber from a fetal (day 15) dysgenic mouse. Fig. 1 A shows calcium currents elicited from holding potentials of -80 and -40 inV. From a holding potential of -80 mV, two components of inward current were observed, a transient component and a maintained component. Changing the steady holding potential from -80 to -40 mV eliminated the transient component and left the maintained component unaltered. For the traces shown, the holding potential was changed from -80 to -40 mV for 100 s; however, only brief prepulses (e.g., 1 s to -30 mV) were required to inactivate the transient component (Beam and Knudson, 1988) . The transient component corresponds to a calcium current (Ic~f,) previously described for developing skeletal muscle from both normal and dysgenic mice (Beam et al., 1986; Beam and Knudson, 1988; Gonoi and Hasegawa, ! 988 ). In con-trast, the maintained component (here termed Ic~m) does not correspond to any previously described calcium current of normal or dysgenic skeletal muscle. Fig. 1 B shows the peak current-voltage relations for the calcium currents Ic~.ft and Ic~dy~ illustrated in Fig. ] A. It is clear from the plot that the two currents are activated over different ranges of transmembrane voltage.
RESULTS
Two Calcium Currents Are Present in Dysgenic Skeletal Muscle
Ic~.d~ IS Mediated by Calcium Channels
Ic.~m is evidently a calcium current because with our recording conditions Ca was the only inorganic ion available to carry inward current at depolarized test potentials. This interpretation is further supported by the observation that Ic~ was reversibly reduced in amplitude by lowering the external Ca concentration (Fig. 2 A) . In three dysgenic myotubes, the peak Ic~.~ measured in 2 mM Ca was only 52 -+ 3% of that measured in 10 mM Ca. In 2 mM external Ca the peak current-voltage relation of Ic~.~ was shifted by ~-20 mV compared to that in 10 mM external Ca. In addition, Ic~,~ was almost completely blocked by the application of 100 #M Cd ( 
B)
. The effect of this concentration of Cd was completely reversible (n = 3; washout not shown). Furthermore, as discussed below, Ic~-,m is quite sensitive to modulation by DHP compounds (Fig. 6) . Fig. 3 demonstrates the relative effectiveness of Ba and Ca as charge carriers for Ic~. Substituting 10 mMBa for 10 mM Ca in the external solution doubled the size of Ic~r~ without significantly altering its kinetics. This effect was very consistent and readily reversible for individual myotubes ( Fig. 3 shows Ca currents obtained before and after switching to external Ba). Altogether, in five dysgenic myotubes the peak current in 10 mM Ba was 203 • 13% of its magnitude in 10 mM Ca. In 10 mM external Ba solution the peak current-voltage relation for Ices was shifted negatively 10-20 mV compared to that measured in 10 mM external Ca.
lc,.~ Is Larger when Barium Carries Charge
Ic,~ Is Distinct from the Slow Calcium Current of Normal Muscle
How is this new current (Ic~.~) related to the slow calcium current (Ic~.s) of normal muscle? I~ and Ic~, have markedly different kinetics. Fig. 4 compares the kinetics of Ic~ recorded from a dysgenic myotube with those of Ic~ recorded from a normal myotube. The currents shown were elicited from steady holding potentials of-40 or -50 mV; thus, Ica.ft is inactivated and Ic~ and Ic~ are shown in isolation. Characteristically, Ic~r~ activates with rapid time-course (time-to-peak 5-10 ms) and displays little or no inactivation for test pulses lasting up to 200 ms (Fig.  4 A) . In contrast, Ic~.s activates very slowly, with a time-to-peak of 200-300 ms (Fig.  4B) . In contrast, Ic~.~ first appears for test pulses to ~-10 mV. Ic~ peaks near + 15 mV, whereas [c~ peaks near + 25 inV. The voltage-dependence of inactivation also differs between Ic~, and Ic~.,. From a steady holding potential of -80 mV, 30-s prepulses to -30,-20,-10, and 0 mV inactivated Ic~., by 21 + 6, 49 _+ 7, 74 + 6, and 88 _+ 3% respectively (n = 12 normal neonatal fibers), but only inactivated Ic~y~ by 11 + 3, 22 -+ 5, 44 _+ 8, and 68 _+ 10%, respectively (n = 6 dysgenic neonatal fibers). Thus, Ic~.,~ activates over a more negative range of membrane potentials (Figs. 4 and 5) and inactivates over a more positive range of membrane potentials than does Ic~,.
It has previously been shown that Ic~., is blocked or potentiated by various DHP compounds (Cognard et al., 1986b; Lamb and Walsh, 1987; Beam and Knudson, 1988) . To assess the relative DHP-sensitivity of Ic~-dy,, calcium currents were recorded from normal and dysgenic myotubes in the absence and presence of Ic~y, is also more sensitive to potentiation by Bay K 8644 than is Ic~ (Fig. 6,  D-F) . Altogether, in four dysgenic myotubes held at -80 mV, 500 nM Bay K 8644 increased peak Ic~,a~ to 318 _+ 62% of control values. In contrast, in nine normal myotubes, also held at -80 mV, this same concentration of Bay K 8644 only increased peak Ic~., by 24 _+ 4%. The differential responses of Ic~-dy~ and Ic~ to Bay K or 5 pM Bay K 8644 did not appear to cause greater potentiation of Ic~ or Ic~.s than 500 nM Bay K 8644.
From the results presented above we conclude that Ic~.o. and Ic~.s are distinct calcium currents having different kinetics, voltage dependence, and pharmacological properties. Table I summarizes the distinguishing characteristics of Ic~.ay~ and the other known calcium currents of skeletal muscle.
Expression of Ic~#, under Different Conditions
In dysgenic myotubes grown directly upon untreated culture dishes, Ic_~.~ is usually so small that it cannot be easily detected. Measuring I~.~ in these cells requires that the leak conductance be very low and that voltage-dependent outward currents be completely blocked. Even with such ideal recording conditions, we found that Ic~ could be detected in only 50% (16/32) of dysgenic myotubes grown on untreated culture dishes. In these 32 cells (from two different cultures) the average (_+ SEM) peak current density of Ic.~m was 0.48 + 0.12 pA/pF (range, 0-2.22), whereas the average peak density of Ic~.ft was 2.46 + 0.32 pA/pF (range, 0-7.4). The level of expression of Ic,~/, appears to vary widely among different cultures of dysgenic myotubes, and also appears to vary with the age of the culture. This variable, lowlevel expression of Ic,~m in dysgenic myotubes grown on untreated culture dishes may reflect the variable presence of contaminating fibroblasts in our primary cultures (see below). Beam et al., 1986 . 4. Cognard et al., 1986a . 5. Cota and Stefani, 1986 . 6. Donaldson and Beam, 1983 . 7. Garcia et al., 1988 . 8. Gonoi and Hasegawa, 1988 I~y~ was more frequently observed in freshly dissociated muscle fibers from fetal or neonatal dysgenic mice (e.g., Fig. 1 ). Out of 43 fibers examined, 35 possessed measureable Ic~y~. In these 43 fibers the average (__ SEM) peak density of Ic~.r was 0.61 _+ 0.08 pA/pF (range, 0-2.12), and the average peak density of Io_ft was 2.76 -0.32 pA/pF (range, 0.7-8.82). We found that dysgenic myotubes grown on a substrate of killed fibroblasts (see Methods) frequently expressed Ic~, sometimes at fairly high density. In 86 dysgenic myotubes grown on killed fibroblasts (from nine different cultures) the average peak density of Ic~.~ was 1.22 __ 0.19 pA/pF (range, 0-8.86 ). In these same myotubes, the average peak density of Ic~.ft was 1.62 -+ 0.17 pA/pF (range, 0-7.24). Of the 86 myotubes examined, 13 expressed only Ica-~ and 24 expressed only Ic~.ft.
The type of fibroblasts used to create the culture substrate did not seem to be important. We used fibroblasts obtained from three different sources: NIH 3T3 cell line, phenotypically normal littermates of dysgenic mice, and dysgenic mice. The average peak current densities of Ic~_~ in myotubes grown upon killed fibroblasts from these different sources were 1.49 _ 0.42 pA/pF (n = 10 randomly selected myotubes), 1.48 _+ 0.51 (pA/pF (n = 5), and 2.35 -+ 0.89 pA/pF (n = 9), respectively.
Is Ic~ Present in Normal Muscle?
An important question is whether Ic.~s is present in normal developing skeletal muscle, where it could easily escape detection due to the obscuring presence of Ic~.s. control current is shown scaled ~" and superimposed upon the current potentiated by Bay K 8644. The scaling factor was determined as the ratio (potentiated current)/(control current), measured at the end of the test pulse. (C) Calcium currents in a dysgenic myotube, 4 d after injection of an expres-< sion plasmid (pCAC6) carrying r cDNA for the rabbit skeletal muscle DHP receptor (Tanabe et al., 1988) . Shown are the unpotentiated current (control), and the current after addition (BK) of 0.5 uM Bay K 8644. Both Ic~,~ and Ic~ are present. HP = -80 mV, test pulses to +50 mV. (D) The control current illustrated in C was scaled as described in B and superimposed upon the current potentiated by 0.5 #M Bay K 8644. The nonsuperimposability of the traces is expected if the total calcium current contained a fast-activating component (corresponding to Ic~.d.) that was potentiated more by Bay K 8644 than the slowly-activating component (corresponding to Ic~). (A and B) Cell B00E42, normal myotube, 11 d in culture, grown on killed fibroblasts; C = 415 pF. 10 mM Ca 2+ + 3 ~aM. (C andD) Cell A00J02, dysgenic myotube, 11 d in culture, injected with rabbit skeletal muscle DHP receptor cDNA on day 7; C = 700 pF. 10 mM Ca 2+ + 3 uM T'I'X.
Because Ic~. activates much faster than Ic .... its presence in normal muscle should cause the activation of inward current to display a fast initial phase followed by a slower phase due to Ic~.~. We did observe such kinetics in calcium currents recorded from normal fetal and neonatal muscle fibers and from normal cultured myotubes, but the fast initial phase could always be removed with a brief (e.g., 1 s) prepulse to remained that Ic~-d~ Was present in normal myotubes at too low a density to be detected without potentiation. Therefore, we looked for Ic~.a. in the presence of racemic Bay K 8644. The following approach was employed. Calcium currents were recorded from normal myotubes grown on a substrate of killed fibroblasts. After recording control calcium currents, 0.5 or 1 #M Bay K 8644 was added to the external solution (Fig. 7 A) . Because Ic~.dr, is greatly potentiated by this compound and Ic~_~ is not (Fig. 6 F) , currents recorded after the addition of Bay K 8644 should have altered activation kinetics if Ic~m were present at significant levels. Such an alteration in activation kinetics should be revealed by the nonsuperimposability of scaled control and potentiated currents. However, application of this test to eight different normal myotubes showed that the scaled control current superimposed accurately upon the current potentiated by Bay K 8644 (Fig. 7 B) .
As described by Tanabe et al. (1988) , injection of an expression plasmid (pCAC6) carrying cDNA that encodes the rabbit skeletal muscle DHP receptor into developing dysgenic myotubes restores both Ic~ and E-C coupling. In one instance, such an injected dysgenic myotube expressed both Ic~., and a prominent Ic~r~ (Fig. 7 C) . Even in the absence of Bay K 8644, I~.a~ imparted a rapid initial phase to the current that could not be removed by a brief prepulse. In the presence of Bay K 8644, Ic~-d~ was potentiated to a greater degree than Ic~, and the rapid initial phase became even more prominent. The predicted change in activation kinetics (discussed above) became very apparent once the control current was scaled and superimposed upon the potentiated current (Fig. 7 D) .
How small would Ic~-d~ have to be to escape detection in normal muscle? To address this question, we modeled calcium currents that contained two components, one having time course and sensitivity to Bay K 8644 corresponding to Ic~rs, the other corresponding to Ic~.,. This analysis indicated that altered activation kinetics could be easily detected if Ic~dr, composed only 5% of the current (which in these myotubes averaged 17.62 pA/pF) recorded before exposure to Bay K 8644. Thus, to have escaped detection in normal muscle, Ic~-~ would have had to be present at an average density of <0.88 pA/pF, which is lower than the average density of Ic~.
(1.22 pA/pF) measured in dysgenic myotubes grown on killed fibroblasts. Although these observations are not conclusive, they suggest that Ic~ is absent from normal skeletal muscle, or at least present at lower density than in dysgenic skeletal muscle.
Relative Calcium Current Densities in Dysgenic and Normal Muscle
As mentioned above, in 43 dysgenic (fetal or neonatal) muscle fibers the average peak density of I~.d~ was 0.61 + 0.08 pA/pF, and the average peak density of Ic~.ft was 2.76 _+ 0.32 pA/pF. For comparison, in 35 normal (fetal or neonatal) fibers the average peak density of Ic~., was 6.30 _+ 0.57 pA/pF (range, 2.33-17.83) and the average peak density of Ic~f, was 2.24 + 0.25 pA/pF (range, 0.47-6.35). Thus, for cells that have developed entirely in vivo, Ic~-dr~ in dysgenic muscle is present at roughly 10-fold lower density than is Ic~ in normal muscle. In contrast, the densities of Ic~.f, are nearly equal in freshly dissociated dysgenic and normal muscle.
In 86 dysgenic myotubes grown on killed fibroblasts the average peak density of Ic~r~ was 1.22 _+ 0.19 pA/pF and the average peak density of Ice.f, was 1.62 + 0.17 pA/pF. Again for comparison, in 31 normal myotubes (from six different cultures grown on killed fibroblasts) the average peak density of Ic~ was 14.24 _+ 1.08 pA/ pF (range, 3.47-26.13 ) and the average peak density of Ic~.t~ was 3.70 +_ 0.82 pA/pF (range, 0-18.82). Thus, for cells that have developed in vitro, Ica~r~ is present at roughly 12-fold lower density than is Ic~. This result is in good agreement with the 10-fold difference that was found for freshly dissociated muscle fibers.
DISCUSSION
Comparison of Ic~.~ with Other Calcium Currents
The present results characterize a previously undescribed calcium current in dysgenie skeletal muscle. This current, Ic~.d~, is kinetically and pharmacologically distinct from the L-type calcium current (Ic~) of normal skeletal muscle: it has faster activation kinetics, it activates over a more negative range of membrane potentials, inactivates over a more positive range of membrane potentials, and it is severalfold more sensitive to DHP compounds than Ic~. In addition, the permeability characteristics of the calcium channel responsible for Ic~y~ are different from those of the channel responsible for Ic~, because the amplitude of Ic~ is doubled by substituting Ba for Ca in the external medium (Fig. 3) , while the amplitude of Ic~ is affected little or not at all (Donaldson and Beam, 1983; Beam and Knudson, 1988) .
Ic~ has kinetics that are very similar to a calcium current (Ic~.fm) previously described for frog skeletal muscle fibers (Cota and Stefani, 1986) , and recently reported for rat and rabbit skeletal muscle fibers . However, these two calcium currents respond very differently to dihydropyridine drugs. ICa-dy~ of dysgenic skeletal muscle is very sensitive to DHPs (Fig. 6) , whereas Ic,.fm of norreal skeletal muscle is insensitive to DHP calcium channel blockers (Arreola et al., 1987; Garcia et al., 1988) . Thus, based on their different pharmacological properties, we conclude that Ic~. and Ic~.fm are distinct currents.
Taken together, the pharmacological and kinetic data support the idea that at least three different calcium currents (Ic~.ft, Ic~.fm, and Ic~) are expressed in normal skeletal muscle. Additional support for this conclusion is provided by the results of Caffrey et al. (1987 Caffrey et al. ( , 1988 for clonal cell lines derived from rodent muscle. Further, our present data indicate that dysgenic skeletal muscle expresses a fourth calcium current (Ic~.~) that is distinct from Ic~ft, Icier, and Ic~ (Table I) .
What type of channel mediates Ice,n? In many respects Ic~ resembles the L-type calcium current of cardiac muscle (Bean, 1985) . Ic~ and cardiac L-current have similar kinetics, voltage dependence, and sensitivity to DHPs. Both pass Ba about twice as well as Ca. The primary difference between Ic~r, and cardiac L-current is that Ic~y~ does not display prominent Ca-dependent inactivation. Thus, even with Ca as the charge carrier, Ic~.d~ decays little during a 200 ms test pulse, and the kinetics of the current are unchanged upon replacement of Ca with Ba (Fig. 3) . These results suggest that the channel mediating Ic~y~ is distinct from the cardiac L-type channel. However, the inactivation properties of the cardiac channel might be altered if it were expressed in skeletal muscle.
The kinetics and voltage-dependence of Ic~y~ also strongly resemble those of neuronal L-type calcium current (Nowycky et al., 1985; Fox et al., 1987) . However, unlike Ic,-d~, neuronal L-current elicited from a holding potential of -80 mV is not much affected by DHP calcium channel blockers (Fox et al., 1987; Bean, 1989; McCobb et al., 1989) . A calcium current in fibroblasts that is potentiated by the DHP (+)202-791 (Chen et al., 1988 ) also has kinetics resembling Ic~.a~. It cannot be stated whether the fibroblast current shows other similarities to Ic~.~ because Chen et al. (1988) did not report whether this current shows calcium-dependent inactivation or is sensitive to DHP calcium channel blockers at negative holding potentials.
Previous experiments have shown that E-C coupling and Ic~ can be restored in dysgenic myotubes by co-culture with pure populations of living, nondysgenic fibroblasts; dysgenic fibroblasts are ineffective (Courbin et al., 1989) . This "rescue" of dysgenic muscle appears to require the fusion of living fibroblasts with cultured myotubes (Chaudhari et al., 1988) . As a control for these co-culture experiments, dysgenic myotubes were grown on a layer of killed fibroblasts. As reported here, the expression of Ic~-dr, is enhanced in dysgenic myotubes grown on substrates of killed fibroblasts from either normal or dysgenic mice. It should be emphasized that dysgenic myotubes grown on killed fibroblasts do not exhibit restored E-C coupling (see below) or the Ic~, characteristic of normal muscle.
The mechanism by which a substrate of killed fibroblasts enhances the expression of Ic_~.~ remains uncertain. Presumably the fibroblasts provide an extracellular matrix resembling that present during muscle development in vivo because Ic~y, is frequently present in acutely dissociated dysgenic muscle fibers. A similar extracellular environment may be present to a lesser extent in conventional cultures (grown directly on plastic dishes) in which dysgenic fibroblasts have proliferated; such an occurrence may explain the report of Bournaud et al. (1988) of "partial restoration of the slow calcium current" in aged cultures of dysgenic myotubes, and may also explain why we occasionally recorded Ic~.~ from dysgenic myotubes grown on untreated culture dishes. Beam et al. (1986) did not describe a calcium current in dysgenic myotubes corresponding to Ic~, probably because their myotubes were grown directly on untreated culture dishes in the absence of fibroblasts. Experiments are currently underway to further clarify the relationship between developmental substrate and the expression of Ic~-dw
Biological Implications of Ic,~
Recent experiments have shown that E-C coupling and Ic~ can be restored in dysgenic skeletal muscle by injecting, into myotubes in culture, cDNA for the normal skeletal muscle DHP receptor (Tanabe et al., 1988) . These results support the hypothesis (Rios and Brum, 1987 ) that this DHP receptor has a dual function, serving both as the Ic~ calcium channel and as the voltage sensor for E-C coupling. Because Ic~ presumably reflects the presence of an L-type calcium channel, in the same class as the channel that mediates Ic~, it is reasonable to ask whether the channel responsible for Ic~ could also serve in skeletal muscle E-C coupling. Several lines of evidence suggest that it cannot. The presence of Iced. is not correlated with the restoration of E-C coupling in dysgenic skeletal muscle. Dysgenic myotubes may express Ic~m (this study), yet do not have functional E-C coupling (Powell and Fambrough, 1973; Klaus et al., 1983) . Furthermore, dysgenic myotubes grown on killed fibroblasts sometimes express Ic~-d~ at high densities (up to 8.86 pA/pF, well within the range of magnitudes observed for Ic~_, in normal myotubes; Fig. 4 A) yet these same myotubes lack normal E-C coupling. The presence of Ic~,~ in dysgenic skeletal muscle, in the absence of E-C coupling, suggests that not all L-type calcium channels are equivalent in their ability to couple skeletal muscle excitation to contraction. E-C coupling in skeletal muscle apparently requires the presence of the specific DHP receptor that is associated with, and perhaps mediates, Ic~.s.
One possibility raised by our results is that the channels underlying Ic~r~ constitute the DHP-binding sites reported for dysgenic skeletal muscle. Although fivefold lower than for normal muscle, the number of high-affinity DHP-binding sites in dysgenic muscle is still substantial (Pincon-Raymond et al., 1985) . Previous to the discovery of Ic~d~, it had seemed puzzling that dysgenic skeletal muscle, which completely lacks Ic,_~, could still bind DHPs.
The genetic origin of Ic~ remains unclear. One possibility is that the ICa_dy ~ channel is the product of a gene that is silent in normal skeletal muscle but becomes expressed as a result of the muscular dysgenesis mutation. For example, the presence of Ic~., might suppress the expression of Ic,~. The simultaneous presence of both Ica~ and Ic~.~ in the pCAC6-injected dysgenic myotube shown in Fig. 7 C does not necessarily eliminate this as a possibility. Even if Ic~_~ does suppress the expression of Ic~_~, there might not have been a sufficient length of time after the injection to have eliminated preexisting Ic_~_~ channels. Alternatively, Ic~.0~ may represent expression of a mutated gene for the skeletal muscle DHP receptor. Restriction-fragment analysis indicates that the structural gene for this protein is altered in muscular dysgenesis; in addition, a low level of mRNA related to the skeletal muscle DHP receptor may be present in dysgenic muscle (Tanabe et al., 1988) . Whatever the source of Ic~,, it will be important to determine the primary sequence of the protein responsible for this current. Because E-C coupling is nonfunctional in dysgenic muscle, differences in the primary sequences of the Ica-~ and Ic~.~ calcium channels may reveal those regions of the protein necessary for E-C coupling.
